Sasse et al identified patients with early Hodgkin's disease who have a favorable prognosis. The authors are from the German Hodgkin Study Group.
Patient selection: Hodgkin disease
Parameters:
(1) clinical stage
(2) prognostic factors
Prognostic factors:
(1) large mediastinal mass
(2) extranodal disease
(3) elevated ESR
(4) >= 3 lymph node areas involved
(5) massive spleen involvement
Clinical Stage
Findings
Prognosis (Trial Group)
I or II
none
favorable (HD7)
spleen only (factor 5)
favorable (HD10)
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology